Abbott Laboratories Stock - Thursday chart check after 52-week low

Abbott Laboratories shares have been under clear pressure in recent months and recently touched a new 52-week low. On this Thursday, the focus shifts to the technical picture, including key support levels and volatility, against a backdrop of cautious analyst optimism.

Edited by ad hoc news Chart & Technicals Desk. Verified prior to publication on 06/18/2026, 14:07 UTC. Details in the imprint.

Abbott Laboratories (US0028241000) remains in a weak technical phase after a series of lower highs and a fresh 52-week low earlier this week. The stock’s current chart setup on Thursday is shaped by a broken support zone and subdued momentum, according to recent market data.

What the latest trading shows

On Wednesday, Abbott Laboratories shares traded in a range between about $87.87 and $91.58, ending the session near $88.65, according to real-time quote data. Robinhood quote page This leaves the stock roughly 3% below the prior intraday high.

Some market services highlight that the stock has fallen markedly from the beginning of 2026, when it traded around $125.30, implying a decline of close to 30% year-to-date. MarketBeat overview The move has pushed Abbott into the weaker half of large-cap US healthcare equipment names.

Thursday focus on chart and technicals

Chart-oriented investors are now watching how Abbott behaves around the high-$80s band, which has switched from support to a potential resistance area after the recent slide. The stock also appears to be trading clearly below its early-year levels, underlining a sustained downtrend.

Volatility has picked up in recent sessions, as shown by the relatively wide daily ranges between intraday highs and lows. Net-net, the pattern reflects ongoing selling pressure, while no fresh company-specific news flow has yet provided a visible technical catalyst.

How the company makes its money

Abbott Laboratories generates most of its revenue from diversified healthcare products, including diagnostics systems, medical devices, established branded generics and nutritional products such as the Similac infant formula range. The group operates globally, with a strong footprint in both developed and emerging markets.

Where the stock trades today

Abbott Laboratories shares (US0028241000) trade on the New York Stock Exchange at about $88.65 as of 06/18/2026, 14:00 UTC.

Key facts on Abbott Laboratories stock

• Company: Abbott Laboratories Inc.
• ISIN: US0028241000
• WKN: 850103
• Ticker: ABT
• Venue: NYSE
• Price (as of 06/18/2026, 14:00 UTC): 88.65 USD
• Market cap: 154,000,000,000 USD (as of 06/18/2026)
• Sector / Industry: Health Care / Health Care Equipment & Supplies
• Index membership: S&P 500
• Next earnings date: not officially scheduled

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.